- An mRNA vaccine is based on RNA of the novel coronavirus: Experts
- Several vaccines are now clinically available under emergency use
- Pfizer and Moderna are mRNA vaccines
Washington: Patients without COVID-19 symptoms are far less likely to test positive, and unknowingly spread COVID-19 ten days after receiving a second dose of a messenger RNA vaccine, compared to those who have not been vaccinated, a study says. Researchers from Mayo Clinic in the US noted that several vaccines are now clinically available under emergency use authorisation and have demonstrated efficacy against symptomatic COVID-19. However, the impact of vaccines on asymptomatic SARS-CoV-2 infection is largely unknown, they said.
The Pfizer-BioNTech and Moderna messenger RNA (mRNA) vaccines for COVID-19 are authorised for emergency use in many countries. An mRNA vaccine is based on the segments of the genetic material, or RNA, of the novel coronavirus.
Also Read: One Year After WHO Declared COVID-19 A Global Pandemic, The World Continues To Be Under The Threat Of Coronavirus Variants
With two doses of a mRNA COVID-19 vaccine, people with no symptoms showed an 80 per cent lower adjusted risk of testing positive for the disease after their last dose, according to the researchers. The findings, published in the journal Clinical Infectious Diseases, underscore the efficacy of mRNA vaccines for COVID-19 to significantly limit the spread of COVID-19 by people with no symptoms who may unknowingly spread the infection to others.
We found that those patients without symptoms receiving at least one dose of the first authorised mRNA COVID-19 vaccine, Pfizer-BioNTech, 10 days or more prior to screening were 72 per cent less likely to test positive. Those receiving two doses were 73 per cent less likely, compared to the unvaccinated group, said Aaron Tande, a Mayo Clinic infectious diseases specialist and co-first author of the paper.
After adjusting for a range of factors, researchers found an 80 per cent risk reduction of testing positive for COVID-19 among those with two doses of an mRNA COVID-19 vaccine. The researchers retrospectively looked at a cohort of 39,000 patients who underwent pre-procedural molecular screening tests for COVID-19.
Over 48,000 screening tests were performed, including 3,000 on patients who had received at least one dose of an mRNA COVID-19 vaccine, they said. According to the researchers, these screening tests were part of routine COVID-19 testing prior to treatments not related to COVID-19, such as surgeries and other procedures. Patients in the vaccinated group had received at least one dose of a messenger RNA COVID-19 vaccine, they added.
Also Read: COVID Vaccination: Experts Answer Queries Related To Coronavirus Vaccine And Comorbidities
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
NDTV – Dettol Banega Swasth India campaign is an extension of the five-year-old Banega Swachh India initiative helmed by Campaign Ambassador Amitabh Bachchan. It aims to spread awareness about critical health issues facing the country. In wake of the current COVID-19 pandemic, the need for WASH (Water, Sanitation and Hygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign highlights the importance of nutrition and healthcare for women and children to prevent maternal and child mortality, fight malnutrition, stunting, wasting, anaemia and disease prevention through vaccines. Importance of programmes like Public Distribution System (PDS), Mid-day Meal Scheme, POSHAN Abhiyan and the role of Aganwadis and ASHA workers are also covered. Only a Swachh or clean India where toilets are used and open defecation free (ODF) status achieved as part of the Swachh Bharat Abhiyan launched by Prime Minister Narendra Modi in 2014, can eradicate diseases like diahorrea and become a Swasth or healthy India. The campaign will continue to cover issues like air pollution, waste management, plastic ban, manual scavenging and sanitation workers and menstrual hygiene.